Ovarian Cancer Identification on CT Using Deep Learning
Condition(s) studied
Study summary
Ovarian cancer remains the deadliest gynecologic malignancy, with poor survival rates largely due to late-stage diagnosis. Early detection is crucial, yet no universally accepted screening method exists. Current imaging techniques and biomarkers, such as CA-125, have limitations in specificity and sensitivity. This study aims to develop and evaluate a deep learning-based computer-aided diagnosis tool (CAT-OV), for ovarian cancer detection using CT imaging. The system integrates a Body Part Regression (BPR) model for pelvic localization and a Multiple Instance Learning (MIL) ensemble classifier for cancer prediction. The model was trained and validated using retrospective datasets from Taiwan, the United States, and a nationwide real-world cohort. Stringent preprocessing and quality control measures were implemented to enhance model accuracy. Results highlight the potential of AI-driven CT screening in improving early detection, though further validation is needed for clinical adoption.
Eligibility
Primary outcome measure(s)
- Performance of a deep learning-based computer-aided diagnosis tool (CAT-OV) for identification of primary ovarian cancer on CT — Perioperative/Periprocedural 180 days
Sensitivity, Specificity, Accuracy, PPV, NPV, AUC
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Chang Gung Memorial Hospital | Taoyuan City | Guishan District | Completed |
| Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital | Taoyuan | Guishan | Recruiting |
More Chang Gung Memorial Hospital trials in Taiwan
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06851429 on ClinicalTrials.gov ↗ ← All trials in Taiwan